Sedana Medical seeks approval for inhaled sedation candidate Sedaconda
Sedana Medical has submitted an application seeking approval for its drug candidate Sedaconda (isoflurane), previously called IsoConDa, for inhaled sedation in intensive care. The application has been filed with the German Medicines Agency BfArM and various other European Medicines Agencies via the DCP procedure. The market approval application is based on the results of the […]